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Abstract
Background: Integrins are important cellular receptors for collagens. Within the glomerulus, podocytes regulate
the integrity of the glomerular basement membrane (GBM) by sensing the presence of collagen and regulating
collagen IV synthesis. The present study evaluates the role of integrin a2 (ITGA2) in cell-matrix interaction.
Methods and Results: ITGA2-deficient mice had normal renal function but moderate proteinuria and enhanced
glomerular and tubulointerstitial matrix deposition. Electron microscopy demonstrated irregular podocyte-matrix
interaction, causing pathological protrusions towards the urinary (podocyte) side of the GBM. These characteristic
subepithelial bulges mimic the renal phenotype of mice, which are deficient in another collagen receptor,
discoidin domain receptor (DDR)1. Using immunogold staining, ITGA2 expression was found to localize to the
basolateral site of the podocyte foot processes. ITGA2-deficient mice overexpressed transforming growth factor
(TGF)b and connective tissue growth factor (CTGF) compared with wild-type mice. Using in situ hybridization,
tubular cells were found to be the primary site of TGFb synthesis and podocytes the source of CTGF in ITGA2-
deficient mice.
Conclusion: These findings support our hypothesis that both these collagen receptors (ITGA2 and DDR1) play a
similar role within the kidney. Further, cell-matrix interaction via collagen receptors seems to be crucial for
maintenance of normal GBM architecture and function. Targeting collagen receptors such as ITGA2 might be a
new form of treatment for progressive fibrotic diseases.
Introduction
Integrins are cellular receptors that are important for
sensing the extracellular environment and adjacent cells.
Each cell type expresses a characteristic combination of
a- and b-subunits. The a-subunit of an integrin predicts
its ligand specificity, whereas the cytoplasmic tail of the
b-subunit interacts with the cytoskeleton and with pro-
teins involved in signal transduction. Integrin a1h a s
only one known partner, b1; a1b1 is an important
receptor for collagens and laminins in basement mem-
branes [1,2]. The most abundant integrins within the
glomerulus are a1b1, a2b1a n da3b1. Integrin a1b1i s
expressed in all glomerular cell types [3], and plays a
crucial role in cell proliferation and collagen turnover,
and in sensing extracellular collagen levels and downre-
gulating endogenous collagen synthesis [4]. a1b1i n t e g -
rin is expressed primarily on mesangial cells, a2b1
primarily on endothelial cells, and a3b1 on podocytes
[5]. Integrin a1-knockout mice are fertile with no overt
phenotype [5-7], whereas targeted deletions of a4a n d
a5 integrins are lethal during embryogenesis [8].
Embryonic fibroblasts derived from a1-deficient animals
a r eu n a b l et os p r e a do nc o l l a g e nI V[ 9 ] .T h er o l eo f
a1b1 integrin in collagen-dependent cell proliferation,
adhesion, matrix remodeling and mesangial cell migra-
tion points to integrins playing a role in the pathogen-
esis of collagen diseases such as the hereditary type IV
collagen disease Alport syndrome (AS).
AS is caused by mutations in the a3/4 or 5 chains of
type IV collagen, which result in proteinuria and renal
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the glomerular basement membrane (GBM). During
embryogenesis, the premature GBM, consisting of a1/
a1/a2 (IV) chains, is produced by endothelial cells and
podocytes. The mature GBM, containing a3/a4/a5 (IV)
chains, is built solely by podocytes [11-14]. Mutations in
the a3/a4/a5 (IV) chains in AS result in characteristic
ultrastructural changes in the GBM [10]. One important
step in the pathogenesis of AS is thought to be an
altered cell-matrix interaction via the podocyte collagen
receptors. For example, ASmice, which carry an addi-
tional knockout for the integrin a1 gene, show delayed
onset and slower disease progression [5].
Integrins can be activated by triple-helix type I and IV
collagens [15]. Binding of integrin to its ligands influ-
ences the actin cytoskeleton via activation of cdc42,
Rac1 and focal adhesion kinase (FAK) [16]. The activa-
tion of a1b1 integrin downregulates collagen synthesis
[4], suggesting that the functional loss of this integrin
could predispose the host to augmented sclerosis after
injury. Transforming growth factor (TGF)b is known to
stimulate the production of the extracellular matrix
(ECM) in podocytes [17]. As integrin-mediated FAK
activation leads to the downregulation of TGF-b recep-
tors, loss of a1b1 function results in increased collagen
expression [18].
The possible role of collagen receptors other than
integrins, such as discoidin domain receptor (DDR)1 in
renal disease has been previously addressed by our
group [19,20]. Loss of DDR1 delays renal fibrosis in AS
[20]. The role of a2b1 integrin in renal pathology is less
clear. Examination of integrin a2 knockout mice showed
a multifaceted phenotype including defects of branching
morphogenesis, hemostasis and a partially defective
platelet interaction with collagen [7,21]. The nonlethal
phenotype of the a2-deficient mice implies that many of
the key functions of a2b1 can be mimicked by other
integrins. In the present study, we analyzed the renal
phenotype of integrin a2-deficient mice, and found that
loss of integrin a2 results in irregular podocyte–matrix
interaction, causing pathological protrusions towards the
urinary (podocyte) side of the GBM and increased
TGFb and connective tissue growth factor (CTGF)
expression.
Materials and methods
The animal care and experiments were performed
according to the Declaration of Helsinki and the Guide
for the Care and Use of Laboratory Animals (NIH).
Knockout mice
The methods for generation of integrin a2k n o c k o u t
mice and for PCR-based genotyping have been described
previously [7,21]. The ITGA2 knockout and wild-type
mice (provided by B. Eckes, University of Cologne,
Cologne, Germany) used here were bred on a C57Bl6
background under pathogen-free housing conditions at
the local animal facility with a 12-h light/dark cycle and
unlimited access to food and water. The DDR1
-/- mice
were provided by W. Vogel, University of Toronto, Tor-
onto, Canada, and the collagen (IV) a3( C O L 4 A 3 )
-/-
mice by Jackson Immunoresearch Laboratories (West-
grove, PA, USA). COL4A3
-/- mice were crossbred to the
C57Bl6 background for nine generations. No animals
were lost due to infections during monitoring. For wes-
tern blotting, histology and assessment of urea levels,
animals were examined at 100 and 150 days of age.
Western blot analysis
Three to four kidneys from either the wild-type or
ITGA2-deficient groups were homogenized in a solution
of Tris-buffered saline (TBS) containing a cocktail of pro-
tease inhibitors (phenylmethylsulfonyl fluoride (PMSF),
leupeptin and pepstatin). Next, 20 μg of protein (equal
loading dose shown by the bicinchoninic acid (BCA) pro-
tein assay) was solubilized in lithium dodecyl sulfate
(LDS) sample buffer and separated in a 4 to 12% gel
(NuPage Novex Bis-Tris Gel; Invitrogen, Carlsbad, CA,
USA), transferred to a polyvinylidene fluoride membrane,
and blocked with 5% dry milk powder in TBS with Tri-
ton X-100 (TBST). The membrane was incubated over-
night with mouse anti-TGFb1 (1:2000; R&D Systems,
Minneapolis, USA) and rabbit anti-CTGF (1:2000; Abcam
Limited, Cambridge, United Kingdom), then with the
horseradish peroxidase-conjugated secondary antibody
(Dako, Hamburg, Germany) for 1 hour at room tempera-
ture. The blots were developed by chemoluminescence
using enhanced chemiluminescence (GE-Healthcare,
Freiburg, Germany). Protein expression was analyzed by
densitometry (Kd1 software; Kodak, Rochester, NY, USA).
In situ hybridization
Paraffin-embedded sections (5 μm thick) were dewaxed
and rehydrated in decreasing concentrations of ethanol.
After two washes in phosphate-buffered saline (PBS),
sections were partially digested with 6 μg/ml proteinase
K (Qiagen, Hilden, Germany) for 30 min. Sections were
post-fixed with 4% formaldehyde for 5 minutes before
hybridization with a digoxigenin (DIG)-labeled RNA
probe specific for either TGFb mRNA or CTGF mRNA.
Probes for in situ hybridization were labeled with DIG
by in vitro transcription in the presence of DIG-UTP
using reverse transcriptase PCR products of TGFb and
CTGF as templates, linked to promoters of SP6 or T7
RNA polymerase by molecular cloning. DIG-labeled
probes were hybridized to the sections in the hybridiza-
tion solution at 42°C overnight. Subsequently, sections
were washed twice in 2 × sodium citrate buffer and
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Page 2 of 10PBS. Bound probes were detected with (1:500) rabbit
anti-DIG-AP (Roche, Penzberg, Germany) in TBS con-
taining 5% dry milk powder, and visualized using the
diluted alkaline phosphatase substrate nitro blue tetrazo-
lium chloride/5-bromo-4-chloro-3’-indolyphosphate
p-toluidine salt (NBT/BCIP) (1:50; Roche, Penzberg,
Germany) at pH 9.5.
Immunohistochemistry of tissue sections and scoring of
fibrosis
From each group, three to five mice were killed and trans-
cardially perfused with a solution of paraformaldehyde and
glutaraldehyde; kidneys were immersion fixed as described
previously [8]. Semi-thin and thin sections of paraffin
wax-embedded kidney were cut (Ultracut UCT ultrami-
crotome; Reichert Inc., Depew, NY, USA) into sections
5 μm thick, then dewaxed, rehydrated in graded alcohol
and blocked with 5% bovine serum albumin (BSA) in TBS
at room temperature. Endogenous peroxidases were
blocked by treatment with 3% hydrogen peroxide in PBS
for 10 minutes. Primary antibodies (rabbit anti-mouse
EHS-laminin and rabbit anti-mouse fibronectin, 1:1000;
gift from M. Paulsson, Cologne, Germany) were incubated
overnight at 4°C. Next, sections were incubated with goat
anti-rabbit Cy3 (Jackson ImmunoResearch Laboratories
Inc.) as a secondary antibody and analyzed under a micro-
scope (Axiophot; Zeiss, Göttingen, Germany). Stained sec-
tions were scored for protein deposition as described
previously [10]. Glomerulosclerosis was defined as the loss
of >50% of the glomerular lumen due to matrix accumula-
tion. Tubulointerstitial fibrosis was evaluated in a similar
manner by grading by a blinded observer of 12 kidney
sections, each from three animals per group, for accumu-
lation of ECM (graded as 0, 1+ and 2+).
Electron microscopy and immunogold detection of
integrin a2
For ultrastructural electron microscopy, kidney samples
(4-mm
3) taken from three mice per group were fixed in
Karnovsky solution and embedded in epoxy resin as
described previously [22]. Ultrathin sections were
prepared (Reichert-Jung Ultracut E; Leica, Wetzlar,
Germany) and examined under an electron microscope
(LEO 906E; Zeiss, Oberkochen, Germany). For immuno-
gold staining, kidney samples of 1 mm
3 were fixed and
embedded in a hydrophilic resin (LR-Gold; London
Resin Company, Reading, UK) as described previously
[23]. Ultrathin sections were blocked with 1% BSA in
PBS for 20 min at room temperature. The primary anti-
body (rabbit anti-mouse integrin a2, 1:50 in PBS;
Abcam) was incubated for 1 hour at room temperature.
A secondary antibody (goat anti-rabbit IgG, 1:300 in
PBS; Medac, Hamburg, Germany) was coupled to 16-
nm colloidal gold particles according to standard
protocols [24] and incubated for 20 min at room tem-
perature. Contrast staining with 1% uranyl acetate and
lead citrate was carried out for 10 min each at room
temperature. Negative control experiments were
performed using ITGA2
-/- kidneys and by treating the
sections with 1% BSA instead of the primary antibody.
To exclude binding of uncoupled gold particles to tissue
structures, control sections were incubated with a pure
colloidal gold solution.
Analyses of urine and serum
Proteins from 20 μlo fu r i n eo ft h r e et of i v em i c ep e r
group were precipitated using methanol/chloroform and
dissolved in loading buffer. They were separated in a
pre-cast 4 to 12% gradient polyacrylamide gel (Invitro-
gen) and stained with Coomassie blue, then the protein
bands were densitometrically analyzed [19]. The serum
urea levels of three t five mice per group was deter-
mined using an automatic analyzer (Hitachi 91; Boehrin-
ger Mannheim, Germany).
Statistics
Results are presented S means and standard deviation.
Data were analyzed by one-way analysis of variance
(ANOVA).
Results
Loss of ITGA2 mimics the renal phenotype of DDR1
knockouts (ultrastructural changes in GBM)
Electron microscopy demonstrated local GBM thicken-
ing (Figure 1b, c, white arrowheads ) in ITGA2 knock-
outs. These local changes affected 1 to 3% of the total
GBM, compared with 100% of the GBM affected in AS
(Figure 1g-i) [10]. The protrusions in ITGA2 knockout
micestained very homogeneously (Figure 1-c), similar to
the protrusions found in DDR1 knockouts (Figure 1d-f)
[14]. By contrast, the splitting of the GBM found in AS
mice was much more heterogeneous and contained
fibrillar collagens (Figure 1h, i). In AS mice, the GBM
changes were accompanied by severe loss and efface-
ment of the podocyte foot processes (Figure 1i), whereas
the foot processes in ITGA2 knockout mice appeared to
be normal and stayed attached to the GBM even in
areas of GBM thickening (Figure 1b, c).
Loss of ITGA2 causes moderate glomerular and
tubulointerstitial damage
According to our hypothesis, loss of ITGA2 may influ-
ence cell-matrix interactions, including profibrotic
effects due to the upregulation of profibrotic cytokines.
Compared with wild-type controls (Figure 2a, b), 150-
day-old ITGA2
-/- mice (Figure 1e, f) showed minor
glomerular, periglomerular and tubulointerstitial matrix
accumulation. In parallel, total kidney extracts from
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Page 3 of 10Figure 1 Ultrastructural analysis of the glomerular basement membrane. Mice deficient in (a-c) integrin a2 (ITGA2), (d-f) discoidin domain
receptor (DDR)1 and (g-i) collagen (IV) a3 (COL4A3), and (j-l) wildtype controls. Electron microscopy demonstrates a localized, mushroom-like
isodense thickening of the glomerular basement membrane (GBM) in (a-c) ITGA2-deficient mice, compared with (j-l) wild-type mice. (b, c) These
characteristic subepithelial bulges (white arrows) seem to be identical to those observed in (d-f) DDR1 knockouts [19]) (g-i) By contrast, splitting
and thickening of the GBM and fibrillar collagens indicating fibrosis were found in COL4A3-deficent mice. Original magnification: (a, d, g, j) ×
3,000 to 7,000; (b, c, e, f, h, i, k, l) × 15,000 to 30,000. U = urinary space; C = capillary lumen.
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-/- mice showed upregulation of TGFb (Figure 3,
lanes 2 and 3), whereas TGFb in wild-type mice was
barely detectable (Figure 3, lane 1). Additionally, the sig-
nal for CTGF was increased in ITGA2 knockouts (Fig-
ure 2d) compared with wild-type mice. Densitometric
evaluation of the TGFb bands revealed 17.3-fold (100
days) and 14.6-fold (150 days) increases in TGFb and
2.1-fold and 3.6-fold increases in CTGF in ITGA2
knockout mice (Figure 3).
In situ hybridization of TGFb and CTGF confirmed
t h e s er e s u l t s( F i g u r e2 cv e r s u sF i g u r e2 ga n dF i g u r e2 d
versus Figure 2h). TGFb was not detectable in the kid-
neys of wild-type mice, whereas in ITGA2 knockouts,
TGFb was primarily expressed in tubular cells, with a
weak glomerular signal (Figure 2g). Kidneys of wild-type
mice were also negative for CTGF, but in ITGA2 knock-
outs, expression of CTGF was more pronounced in the
glomerulus than in tubular cells (Figure 2h).
Loss of ITGA2 increases glomerular and global
tubulointerstitial matrix deposition and fibrosis
To analyze the effects of ITGA2 knockout on the pro-
duction of ECM and induction of fibrosis, kidney sections
of healthy (Figure 4a) and knockout mice (Figure 4b, c)
were immunostained for EHS laminin (laminin1), a mar-
ker for global glomerular and tubulointerstitial ECM
deposition. The glomerular and tubulointerstitial matrix
deposition was somewhat increased in 100-day-old
ITGA2
-/- mice (Figure 4b) compared with wild-type con-
trols (Figure 4a), and this difference was increased further
in 150-day-old mice (Figure 4c). Increased laminin-1
synthesis in the GBM of ITGA2
-/- mice is shown at
higher magnification in Figure 4 (b, c, insets)
Fibronectin staining also demonstrated moderate glo-
merular, periglomerular and tubulointerstitial deposition
in 150-day-old ITGA2
-/- mice (Figure 4e) compared with
wild-type controls (Figure 4d). The tubulointerstitial
Figure 2 Renal histology in integrin a2 (ITGA2)-deficient mice. Compared with (a, b) wild-type controls, loss of ITGA2 caused (e-f) minor
glomerular, periglomerular and tubulointerstitial damage. In situ hybridization localized elevated transforming growth factor (TGF)b expression in
ITGA2 knockouts to the tubular space (g), whereas (h) upregulation of connective tissue growth factor (CTGF) seemed to be focused on the
glomerular space.
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Page 5 of 10Figure 3 Upregulation of pro-fibrotic factors. Integrin a2 (ITGA2) knockouts showed increased levels of transforming growth factor (TGF)b
and connective tissue growth factor (CTGF) in whole kidney extracts.
Figure 4 Immunostaining for extracellular matrix and scar tissue. (a-c) EHS laminin; (d, e) fibronectin. Compared with (a) 150-day-old wild-type
control mice, (b) 100-day-old and (c) 150-day-old Integrin a2 (ITGA2) knockout mice expressed increased amounts of extracellular matrix. (e) In parallel,
150-day-old ITGA2 knockouts showed accumulation of tubulointerstitial and glomerular scar tissue compared with (d) wild-type mice of the same age.
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Page 6 of 10fibrosis score (range 0 to 2) was 1.1 at 150 days in ITGA2
knockouts compared with 0.3 in wild-type mice. In paral-
lel, the glomerulosclerosis index (range 0 to 2) increased
to 0.7 in ITGA2
-/- mice at 150 days compared with 0.4 in
their wild-type littermates.
Localization of integrin a2 expression
Immunostaining localized integrin a2s o l e l yt ot h e
glomeruli, whereas the tubules remained unstained
(Figure 5a). At higher magnification, cells sitting on the
outer side of the GBM, most probably podocytes,
expressed integrin a2 (Figure 5a insert). These results
were further strengthened by immunogold localization:
ITGA2 was found primarily at the basal side of the
podocyte foot processes close to the GBM (Figure 5d, e,
white arrows ). The surface of podocytes always showed
staining for ITGA2, but it was never detected on the
surface of endothelial cells (Figure 5d-f).
GBM ultrastructural changes result in moderate
proteinuria
Serum urea level of 150-day-old ITGA2 knockout mice
was 45.3 ± 3 mmol/l and was not significantly increased
compared with healthy mice (Figure 6f). Further, mutant
mice showed moderate proteinuria (Figure 6a-e), with
slightly increased excretion of higher molecular weight
proteins in the 150-day-old knockout mice (Figure 6c)
compared with healthy controls (Figure 6a, which was
in contrast to the severe proteinuria of COL4A3
-/- mice
with ongoing renal failure (Figure 6d).
Discussion
The present study investigated the role of the collagen
receptor integrin a2 in the kidney. Confirming our
hypothesis, type IV collagen receptors were able to
downregulate de novo collagen synthesis as long as the
GBM was intact. This hypothesis was strengthened by
the renal phenotype of DDR1-knockout mice (Figure 1d-
f )[ 1 9 ] .W ew e r ea b l et od e m o n s t r a t et h a tt h el o s so f
integrin a2 expression induces localized matrix overpro-
duction in the GBM similarly to DDR1 knockouts. These
changes lead to moderate proteinuria but are not suffi-
ciently severe to cause further renal damage and eventual
renal failure. Interestingly, the loss of ITGA2 mimics the
renal phenotype of DDR1 knockouts, indicating a similar
role of both collagen receptors within the kidney.
Figure 5 Localization of integrin a2 (ITGA2) expression. (a) Immunohistochemistry of wild-type mice with an antibody to ITGA2 showed
staining solely in the glomeruli, whereas kidney tubules remain unstained. (Inset) At higher magnification, ITGA2 was mainly expressed in cells
along the basement membrane, most probably podocytes. (d, e) Immunogold localization within the glomerulus demonstrated localization of
ITGA2 primarily at the basal side of the podocyte foot processes and close to the glomerular basement membrane (GBM) (white arrows). (d-f)
ITGA2 was not detected on the surface of endothelial cells. (b, c) Negative controls in ITGA2 knockouts. Original magnification: (a) × 100, × 400;
(b-g) 20,000 to 30,000. e = erythrocyte; p = podocyte foot processes; t = tubular cell; TBM = tubular basement membrane.
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Page 7 of 10In patients with mutated type IV collagen genes,
receptors become unable to recognize collagen correctly.
As a consequence, signals suppressing collagen synthesis
are depleted, inducing non-physiological overproduction
(with faulty collagen chains such as a1/a2t y p eI Vc o l -
lagen chains, fibrillar collagens, and various laminins)
[12]. In chronic renal fibrotic diseases such as AS, glo-
merular and tubulointerstitial matrix deposition and
scarring are regulated by TGFb and CTGF. The present
study shows that loss of the collagen receptor integrin
a2 increases the total amounts of renal TGFb and
CTGF. TGFb is known to stimulate the production of
ECM in podocytes [25], thus inducing GBM thickening
in the ITGA2 knockouts. These alternations of the
GBM lead to proteinuria, which in turn eads to second-
ary tubular damage and tubulointerstitial fibrosis. How-
ever, it remains unclear whether this proteinuria triggers
upregulation of TGFb and other chemokines or if the
global loss of ITGA2 itself leads to tubulointerstitial
fibrosis. Future studies should concentrate on the role
of ITGA2 in renal disease and on the possible balancing
role of both ITGA2 and DDR1.
Within the glomerulus, bioactive TGF-b1i sd e r i v e d
from the serum of the capillary lumen or from glomerular
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Figure 6 Proteinuria and renal function in integrin a2 (ITGA2) knockouts. Electrophoresis of urine proteins reveals middle- and high-
molecular weight proteinuria at (b, c) 100 and 150 days compared with (a) healthy wild-type controls. However, the amount of proteinuria in
(e) ITGA2 knockouts (triangles) wa s much lower than in COL4A3 knockouts (with ongoing renal failure and nephrotic syndrome; squares). (f)
Levels of serum urea of ITGA2 knockouts (triangles) were not significantly different from those of healthy controls (circles) at 100 and 150 days.
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Page 8 of 10cells [22]. TGFb upregulates type IV collagen in all glo-
merular cell types [25], and increases promoter activity of
fibronectin and a2 type I collagen genes. Further, a con-
sensus TGF-b element is located in the promoter of the
rat pro a1 type I collagen gene [26]. TGF-b induces the
expression of CTGF via a functional Smad3 binding site in
the CTGF promoter. In diabetic nephropathy, CTGF has
been reported to play an important role in glomerular
alteration by inducing the production of fibronectin and of
collagen types I and IV [27].
According to our hypothesis, podocytes do not only
produce mature GBM components (a3/4/5(IV) collagen)
[13], but also react to altered GBM composition via col-
lagen receptors, leading to matrix overproduction. Integ-
rin a1b1 is crucial for downregulating collagen
synthesis, suggesting that its functional loss could
enhance renal fibrosis [28]. Additionally, in the present
study, the localization of integrin a2a tt h el a t e r a lb a s e
of podocytes points to an important role of integrin a2
in the cell-matrix interaction between the GBM and
podocytes. ITGA2 seems not to be crucial for embryo-
genesis. However, cell-matrix interaction via tyrosine
kinase receptors such as DDR1 and ITGA2 seems to be
very important to the mature kidney, otherwise different
collagen receptors compensating each other’s role would
not exist. Future experiments should focus on the
balanced function and interaction of DDR1 and ITGA2.
Abrahamson et al. recently demonstrated the distinct
role of the podocyte in the preservation and production
of mature GBM components [13]. This group further
verified that collagen receptors, particularly integrins,
are linked to the cytoskeleton of podocytes. The activa-
tion of DDR1 has been shown to influence smooth
muscle cell migration and matrix metalloproteinase
expression [29]; both mechanisms play an important
role in the pathogenesis of AS [5,10,12,30,31]. Future
experiments should focus on the role of collagen recep-
tors such as integrin a2 in the architecture and cytoske-
leton of podocytes. Further, interaction between the
GBM, podocytes and slit membrane might become
increasingly important in the pathogenesis of chronic
fibrotic renal diseases and the pathogenesis (and ther-
apy) of proteinuria.
Our data provide evidence that altered cell-matrix
interaction via collagen receptors such as a2i n t e g r i n
and DDR1 are one important step in the maintenance
and production of ECM and in the sequence of fibro-
genesis. Thus, targeting collagen receptors might be
important in the treatment of progressive fibrotic
diseases.
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